Sparebanken Vest (0G67)
London Exchange · UK · prices in NOK · close of 15 Oct 2026
Key indicators
| Last close | NOK 200.10 |
|---|---|
| 52-week range | 156.69 – 209.75 |
| Return, 1 month / 3 months | +3.0% / +6.4% |
| Return, 1 year / 3 years | +27.3% / +125.0% |
| Trend | Uptrend |
| RSI (14) | 55 |
| Volatility (1 year) | 19.4% |
| Worst drawdown (1 year) | -13.7% |
| Average daily value traded | 0.13M NOK |
| Dividend yield | 6.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Sparebanken Vest is a Norwegian savings bank based in Bergen that serves personal customers and small and medium-sized businesses, mainly along the western coast of Norway. It provides everyday banking such as mortgages, savings accounts, payment services and insurance, alongside loans and financial services for local companies. The bank operates through its own branch network and digital channels, and it also offers investment and advisory services to its customers.
On this site Sparebanken Vest appears as a stock on the London Exchange (UK), code 0G67, with prices in Norwegian kroner (NOK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Sparebanken Vest (0G67) trades on the London Exchange in UK. It last closed at NOK 200.10 on 15 October 2026.
Its price-based Market X-Ray is 67 out of 100 (a fair price profile), ranking 770 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 27.3% and over the last three months it rose 6.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 71 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 8.1% | ||
| From 52-week high | -4.6% | ||
| Momentum | 69 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 6.4% | ||
| 6-month return | 8.2% | ||
| 12-month return, skipping the last month | – | ||
| Stability (higher is calmer) | 88 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 19.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -13.7% | ||
| Liquidity | 23 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.13M NOK | ||
| Zero-volume days | 60.0% | ||
| Income | 66 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 6.0% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −2.1% |
|---|---|
| 1 month | +3.0% |
| 3 months | +6.4% |
| 6 months | +8.2% |
| 1 year | +27.3% |
| 3 years | +125.0% |
| 5 years | – |
Signals
| 50-day / 200-day average | 190.44 / 185.04 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.03 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 27 Mar 2026 | NOK 12.0000 |
| 28 Mar 2025 | NOK 8.5000 |
| 22 Mar 2024 | NOK 7.5000 |
| 26 Oct 2023 | NOK 3.0000 |
| 23 Mar 2023 | NOK 5.5000 |
| 24 Mar 2022 | NOK 4.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.